New Discovery Of A Drug That Can Challenge SARS-CoV-2 . Variants

US researchers have discovered a drug that could be a "challenging game" tool in the treatment of Covid-19 patients, including SARS-CoV-2 variants.

University of Pennsylvania researchers have found that diABZI is highly effective in preventing severe Covid-19 symptoms in mice and can fight many different variants.

These researchers also found that the SARS-CoV-2 virus has the ability to avoid the action of a protein produced by the body's cells when attacked by the virus. That has resulted in a delayed immune response, allowing the virus to enter and infect the respiratory system.

However, when learning more about the immune system, the scientists found that diABZI has components that can stimulate the production of antiviral proteins.

Accordingly, out of a total of 129 mice with Covid-19 treated with diABZI, when pre-evaluated with a control group, the mice receiving this drug had a lower viral load.